NetworkNewsBreaks – ChineseInvestors.com Inc. (C
Post# of 346
(Total Views: 188)
Posted On: 04/17/2019 5:47:20 PM
NetworkNewsBreaks – ChineseInvestors.com Inc. (CIIX) Announces Record Revenues and Year-Over-Year Increases for Q3 2019
Premier provider of financial news and education for the Chinese-speaking community ChineseInvestors.com (OTCQB: CIIX) today released its financial and operational summary for the third quarter of its fiscal year 2019. Among the highlights, the update reported an 81 percent increase in total revenue for Q3FY2019 of $1,444,822, up from $796,304, as well as a 579 percent increase in hemp and CBD sales revenues and 6 percent increase in subscription revenues, all up from the same quarter in the prior year. “This has been an extremely eventful quarter for us, demonstrated by the successful product launches and initiatives that we have taken to consolidate branding and provide ease and accessibility for our consumers,” CIIX CEO Warren Wang said in the news release. “Our financial performance and highlights for the quarter are a testament to the popularity and demand for our CBD and hemp products. As a result, we continue to make significant progress in our business through our investments intended to grow the platform for our consumer product lines. Leading the sales for CBD and hemp products, the Company’s wholly owned foreign entity, CBD Biotechnology Co. Ltd. (“CBD Biotech”), was recently a featured exhibitor at the Vietnam Expo, and introduced our self-branded hemp-infused skincare line and hemp wine, which resulted in an overwhelming reception when our exhibitor inventory sold out within the hour. We have successfully become a key player in the Chinese markets, which is why we are confident the year ahead will be fruitful as we continue expanding our brand recognition for our industrial hemp products beyond China and throughout southeast Asia with the help of our recently appointed CBD Biotech CFO, Alex Hamilton.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Premier provider of financial news and education for the Chinese-speaking community ChineseInvestors.com (OTCQB: CIIX) today released its financial and operational summary for the third quarter of its fiscal year 2019. Among the highlights, the update reported an 81 percent increase in total revenue for Q3FY2019 of $1,444,822, up from $796,304, as well as a 579 percent increase in hemp and CBD sales revenues and 6 percent increase in subscription revenues, all up from the same quarter in the prior year. “This has been an extremely eventful quarter for us, demonstrated by the successful product launches and initiatives that we have taken to consolidate branding and provide ease and accessibility for our consumers,” CIIX CEO Warren Wang said in the news release. “Our financial performance and highlights for the quarter are a testament to the popularity and demand for our CBD and hemp products. As a result, we continue to make significant progress in our business through our investments intended to grow the platform for our consumer product lines. Leading the sales for CBD and hemp products, the Company’s wholly owned foreign entity, CBD Biotechnology Co. Ltd. (“CBD Biotech”), was recently a featured exhibitor at the Vietnam Expo, and introduced our self-branded hemp-infused skincare line and hemp wine, which resulted in an overwhelming reception when our exhibitor inventory sold out within the hour. We have successfully become a key player in the Chinese markets, which is why we are confident the year ahead will be fruitful as we continue expanding our brand recognition for our industrial hemp products beyond China and throughout southeast Asia with the help of our recently appointed CBD Biotech CFO, Alex Hamilton.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)